depression
The company will use the funds to increase the adoption of its new offering, Sage, across healthcare providers, payers and care management organizations.
The DTx solution screens a patient's medical records for potential clinical depression.
HIMSS21
Using formerly siloed data, the juli app helps patients manage complex conditions such as asthma, depression, bipolar disorder, migraine and chronic pain, says juli.co CEO Bettina Hein.
Otsuka intends to invest more than $300 million in an FDA-cleared software app that will apply cognitive therapy principals either with or without prescription drugs.